Cronos Group Inc vs GeneDx Holdings Corp — how do they compare? Cronos Group Inc trades at $3.07 (market cap $1.14B), while GeneDx Holdings Corp trades at $82.5 (market cap $2.44B). The key difference: GeneDx Holdings Corp is far larger — about 2.1× Cronos Group Inc's market cap, and Cronos Group Inc is trading nearer its 52-week high, GeneDx Holdings Corp nearer its low. Which is the better fit depends on your goals.
| CRON | WGS | |
|---|---|---|
Market Cap | $1.14B | $2.44B |
Sector | Health | Technology |
52-Week High | $3.27 | $167.51 |
52-Week Low | $2.30 | $34.51 |
Enterprise Value | $341.13M | $2.48B |
Trailing returns across standard periods
Cronos Group, headquartered in Toronto, Canada cultivates and sells medicinal and recreational cannabis through its medicinal brand, Peace Naturals, and its two recreational brands, Cove and Spinach. Although it primarily operates in Canada, Cronos exports medical cannabis to Poland and Germany. In addition, it has entered joint ventures in Israel, Colombia, and Australia to drive further international cultivation and distribution growth. In the U.S. the company directly sells hemp-derived CBD and has an option to acquire 10.5% of U.S. multistate operator PharmaCann.
Read more on CRON →GeneDx is a patient-centered health intelligence company that specializes in transforming healthcare through the application of genomics. It combines advanced technology with one of the world's largest rare disease genomic datasets to provide clinical-grade exome and genome sequencing, enabling precise and rapid diagnosis for patients with complex medical conditions.
Read more on WGS →